Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective was to determine the effects of BIRB 796 BS on CRP and clinical parameters in
Rheumatoid Arthritis as measures of efficacy, and on population pharmacokinetics and safety
parameters